
Pitacab-C 500 Tablet
Marketer
Doxis Laboratories
Salt Composition
Citicoline (500mg)
Overview Pitacab-C 500 Tablet
Cebria-500 tablets are indicated for managing stroke, head trauma, Alzheimer's disease, and memory impairment associated with Parkinson's disease. This medication safeguards brain cells from injury and facilitates their repair. Cebria-500 may be administered with or without food, but consistent daily timing is recommended for optimal therapeutic levels. Dosage is individualized based on age and specific condition. Follow your physician's prescribed dosage and duration; abrupt discontinuation should be avoided without medical consultation due to potential symptom exacerbation. Potential side effects, including hypotension, abdominal discomfort, diarrhea, cardiac arrhythmias, skin rashes, sleep disturbances, and worsening numbness in affected limbs, are generally transient and self-limiting. Persistent or bothersome side effects warrant medical attention. Prior to commencing treatment, disclose any history of kidney disease, seizures, or epilepsy to your doctor. Comprehensive disclosure of all current medications is essential. Furthermore, inform your physician of pregnancy, pregnancy planning, or breastfeeding before using Cebria-500.
Uses of Pitacab-C 500 Tablet
Managing stroke, head trauma, Alzheimer's, and Parkinson's-related dementia.
Major Benefits of Pitacab-C 500 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Pitacab-C 500 Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Pitacab-C 500 Tablet:
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Pitacab-C 500 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Pitacab-C 500 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Pitacab-C 500 Tablet works:
Neuropathic support provided by Pitacab-C 500 Tablets involves nourishing nerve cells, shielding them from harm, and enhancing their viability. This action is achieved through the stimulation of key neurochemicals, such as phosphatidylcholine and acetylcholine. Concurrently, the medication mitigates the accumulation of free fatty acids at sites of nerve injury.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pitacab-C 500 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Pitacab-C 500 Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Pitacab-C 500 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Pitacab-C 500 Tablet on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney disorders should use Pitacab-C 500 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Pitacab-C 500 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Pitacab-C 500 Tablet :
Should you forget a Pitacab-C 500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pitacab-C 500 Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Diphosphate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Cognitive enhancer |
